[ Price : $8.95]
Editor Jim Dickinson reviews the discouraging history of FDA leadership impotence in handling the kind of allegations just made to...[ Price : $8.95]
FDA advisors recommend revised dermal filler labeling to provide better risk information.[ Price : $8.95]
FDA issues a questions-and-answers clarification to the harmonized E14 guidance on QT/QTc Interval Prolongation and Proarrhythmic ...[ Price : $8.95]
Former FDAer Henry Miller warns that those leading the HHS/FDA transition may look for a commissioner who will make FDAs problems ...[ Price : $8.95]
TNS Media Intelligence says drug company spending on DTC ads continued to decline in the first eight months of this year.[ Price : $8.95]
FDA advisory committee briefing documents say Arpidas investigational antibiotic iclaprim was possibly associated with more deaths...[ Price : $8.95]
FDA tells Novo Nordisk that a planned advisory committee meeting for liraglutide on 3/2/09 has been rescheduled for 4/2 or 4/3.[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Bio-Safe America, Deltex, Innovative Neurotronics, George LeMaitre, Omega Tech L...